NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension

Published on May 29, 2018in Circulation23.603
· DOI :10.1161/CIRCULATIONAHA.117.029930
Sébastien J. Dumas3
Estimated H-index: 3
(French Institute of Health and Medical Research),
Gilles Bru-Mercier1
Estimated H-index: 1
(French Institute of Health and Medical Research)
+ 14 AuthorsSylvia Cohen-Kaminsky11
Estimated H-index: 11
(French Institute of Health and Medical Research)
Sources
Abstract
Background —Excessive proliferation and apoptosis resistance in pulmonary vascular cells underlie vascular remodeling in pulmonary arterial hypertension (PAH). Specific treatments for PAH exist, mostly targeting endothelial dysfunction, but high pulmonary arterial pressure still causes heart failure and death. Pulmonary vascular remodeling may be driven by metabolic reprogramming of vascular cells to increase glutaminolysis and glutamate production. The N-methyl-D-aspartate receptor (NMDAR), a major neuronal glutamate receptor, is also expressed on vascular cells, but its role in PAH is unknown. Methods —We assessed the status of the glutamate-NMDAR axis in the pulmonary arteries of PAH patients and controls, through mass spectrometry imaging, western blotting and immunohistochemistry. We measured the glutamate release from cultured pulmonary vascular cells using enzymatic assays, and analyzed NMDAR regulation/phosphorylation through western blot experiments. The effect of NMDAR blockade on human pulmonary arterial smooth muscle cell (hPASMC) proliferation was determined using a BrdU incorporation assay. We assessed the role of NMDARs in vascular remodeling associated to pulmonary hypertension (PH), both in smooth muscle-specific NMDAR knockout mice exposed to chronic hypoxia and in the monocrotaline rat model of PH using NMDAR blockers. Results —We report glutamate accumulation, upregulation of the NMDAR, and NMDAR engagement reflected by increases in GluN1-subunit phosphorylation, in the pulmonary arteries of human PAH patients. K v channel inhibition and ETAR activation amplified calcium-dependent glutamate release from hPASMCs, and ETAR and PDGFR activation led to NMDAR engagement, highlighting crosstalk between the glutamate-NMDAR axis and major PAH-associated pathways. The PDGF-BB-induced proliferation of hPASMCs involved NMDAR activation and phosphorylated GluN1 subunit localization to cell-cell contacts, consistent with glutamatergic communication between proliferating hPASMCs via NMDARs. Smooth-muscle NMDAR deficiency in mice attenuated the vascular remodeling triggered by chronic hypoxia, highlighting the role of vascular NMDARs in PH. Pharmacological NMDAR blockade in the monocrotaline rat model of PH had beneficial effects on cardiac and vascular remodeling, decreasing endothelial dysfunction, cell proliferation and apoptosis resistance, while disrupting the glutamate-NMDAR pathway in pulmonary arteries. Conclusions —These results reveal a dysregulation of the glutamate-NMDAR axis in the pulmonary arteries of PAH patients, and identify vascular NMDARs as targets for anti-remodeling treatments in PAH.
Figures & Tables
Download
📖 Papers frequently viewed together
687 Citations
360 Citations
36 Citations
References62
Newest
#1Taryn N. Green (University of Auckland)H-Index: 4
#2Justin Raymond Hamilton (Monash University)H-Index: 24
Last. Maggie L. Kalev-Zylinska (Auckland City Hospital)H-Index: 12
view all 13 authors...
AbstractGluN1 is a mandatory component of N-methyl-D-aspartate receptors (NMDARs) best known for their roles in the brain, but with increasing evidence for relevance in peripheral tissues, including platelets. Certain anti-GluN1 antibodies reduce brain infarcts in rodent models of ischaemic stroke. There is also evidence that human anti-GluN1 autoantibodies reduce neuronal damage in stroke patients, but the underlying mechanism is unclear. This study investigated whether anti-GluN1-mediated neur...
15 CitationsSource
#1Robert A. Egnatchik (Vandy: Vanderbilt University)H-Index: 10
#2Evan L. Brittain (VUMC: Vanderbilt University Medical Center)H-Index: 23
Last. Joshua P. Fessel (Vandy: Vanderbilt University)H-Index: 31
view all 19 authors...
Pulmonary arterial hypertension (PAH) is increasingly recognized as a systemic disease driven by alteration in the normal functioning of multiple metabolic pathways affecting all of the major carbo...
31 CitationsSource
#1Asya Makhro (University of Verona)H-Index: 13
#2Qinghai Tian (Saarland University)H-Index: 13
Last. Anna Bogdanova (UZH: University of Zurich)H-Index: 29
view all 8 authors...
This study focuses on characterization of the cardiac N-methyl D-aspartate receptors (NMDARs) as a target for endogenous and synthetic agonists and antagonists. Using isolated perfused rat hearts, we have shown that intracoronary administration of the NMDAR agonists and antagonists has a pronounced effect on autonomous heart function. Perfusion of rat hearts with autologous blood supplemented with NMDAR agonists was associated with induction of tachycardia, sinus arrhythmia and ischemia occurrin...
11 CitationsSource
#1Adam D. Hogan-Cann (UM: University of Manitoba)H-Index: 5
#2Christopher M. Anderson (UM: University of Manitoba)H-Index: 26
Glutamate serves as the dominant central nervous system (CNS) excitatory neurotransmitter, in part by activating N -methyl-D-aspartate receptors (NMDARs). While the structure, function, and distribution of neuronal NMDARs have been extensively elucidated, NMDARs are also expressed across a wide spectrum of non-neuronal cells, including central and peripheral glial cells, endothelium, kidney, bone, pancreas, and others. These receptors are poorly understood compared to neuronal receptors, but the...
74 CitationsSource
#1Thomas BerteroH-Index: 21
#2William M. OldhamH-Index: 20
Last. Stephen Y. ChanH-Index: 51
view all 31 authors...
le Canceropole PACA; la Region PACA; le Conseil Departementale 06; I'INSERM; ARC; IBiSA; Conseil Departemental 06 de la Region PACA; NIH [HL096834, HL124021, P01-HL103455, R56-HL126525, R01-HL090339, HL61795, HL48743, HL108630, GM107618, HL007633, HL128802, HL121174]; American Heart Association; Ligue Nationale contre le Cancer; Fondation Bettencourt-Schueller; French National Research Agency [ANR-11-LABX-0028-01]; Association pour la Recherche sur le Cancer (ARC) [PJA20131200325]; Gilead Scienc...
184 CitationsSource
#1Vidyanand Anaparti (UM: University of Manitoba)H-Index: 10
#2Christopher D. Pascoe (UM: University of Manitoba)H-Index: 14
Last. Andrew J. Halayko (UM: University of Manitoba)H-Index: 70
view all 8 authors...
We have shown that N-methyl-d-aspartate receptors (NMDA-Rs) are receptor-operated calcium entry channels in human airway smooth muscle (HASM) during contraction. Tumor necrosis factor (TNF) augments smooth muscle contractility by influencing pathways that regulate intracellular calcium flux and can alter NMDA-R expression and activity in cortical neurons and glial cells. We hypothesized that NMDA-R-mediated Ca2+ and contractile responses of ASM can be altered by inflammatory mediators, including...
14 CitationsSource
#1Fabrice Antigny (French Institute of Health and Medical Research)H-Index: 28
#2Aurélie Hautefort (French Institute of Health and Medical Research)H-Index: 11
Last. Frédéric Perros (Laval University)H-Index: 47
view all 24 authors...
Background —Mutations in the KCNK3 gene have been identified in some patients suffering from heritable pulmonary arterial hypertension (PAH). KCNK3 encodes an outward rectifier K + channel, and each identified mutation leads to a loss of function. However, the pathophysiological role of KCNK3 in PAH is unclear. We hypothesized that loss of function of KCNK3 is a hallmark of idiopathic and heritable PAH and contributes to dysfunction of pulmonary artery (PA) smooth-muscle cells (PASMC) and endoth...
92 CitationsSource
#1Olga Rafikova (UA: University of Arizona)H-Index: 13
#2Mary L Meadows (Georgia Regents University)H-Index: 5
Last. Stephen M. Black (UA: University of Arizona)H-Index: 68
view all 11 authors...
There is increasing interest in the potential for metabolic profiling to evaluate the progression of pulmonary hypertension (PH). However, a detailed analysis of the metabolic changes in lungs at the early stage of PH, characterized by increased pulmonary artery pressure but prior to the development of right ventricle hypertrophy and failure, is lacking in a preclinical animal model of PH. Thus, we undertook a study using rats 14 days after exposure to monocrotaline (MCT), to determine whether w...
26 CitationsSource
#1Robert H. Friesen (University of Colorado Denver)H-Index: 23
#2Mark D. Twite (University of Colorado Denver)H-Index: 13
Last. D. Dunbar Ivy (University of Colorado Denver)H-Index: 71
view all 10 authors...
Summary Background The safety of ketamine in children with pulmonary hypertension has been debated because of conflicting results of prior studies in which changes in mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) have been widely variable. The goal of this prospective study was to quantitate the effects of ketamine on pulmonary hemodynamics in a cohort of children with pulmonary hypertension under conditions in which variables such as airway/ventilatory management...
14 CitationsSource
#1Jan Marquard (HHU: University of Düsseldorf)H-Index: 10
#2Alin StirbanH-Index: 15
Last. Eckhard Lammert (HHU: University of Düsseldorf)H-Index: 30
view all 11 authors...
In this clinical trial, we investigated the blood glucose (BG)-lowering effects of 30, 60 and 90 mg dextromethorphan (DXM) as well as 100 mg sitagliptin alone versus combinations of DXM and sitagliptin during an oral glucose tolerance test (OGTT) in 20 men with T2DM. The combination of 60 mg DXM plus 100 mg sitagliptin was observed to have the strongest effect in the OGTT. It lowered maximum BG concentrations and increased the baseline-adjusted area under the curve for serum insulin concentratio...
20 CitationsSource
Cited By42
Newest
#1Jiahong Sun (SDU: Shandong University)H-Index: 2
Last. Bo Xi (SDU: Shandong University)H-Index: 32
view all 5 authors...
The regulatory mechanisms of hypertension in youth are incompletely understood. We aimed to identify potential serum metabolic alterations associated with hypertension in adolescents. A 1:1 age- and sex-matched case-control study including 30 hypertensive adolescents aged 12-17 years and 30 normotensive adolescents for the training set and 14 hypertensive adolescents and 14 normotensive adolescents for the test set was performed, which came from one cross-sectional study in Ningxia, China. Hyper...
Source
#1Li Yi (Southern Medical University)
#2JunFang Liu (Southern Medical University)
Last. Mingyan Li (Guangzhou Medical University)
view all 5 authors...
OBJECTIVE This study aimed to determine the effects of emodin on the viability, proliferation and apoptosis of human pulmonary artery smooth muscle cells (PASMCs) under hypoxia and to explore the underling molecular mechanisms. METHODS PASMCs were cultured in a hypoxic environment (1% oxygen) and then treated with emodin. Cell viability, proliferation and apoptosis were evaluated using CCK-8 assay, EdU staining assay, western blot and Mito-tracker red CMXRos and Annexin V-FITC apoptosis detectio...
Source
Last. Huan Chen (BIDMC: Beth Israel Deaconess Medical Center)
view all 9 authors...
Source
#1Abhinav P. Acharya (University of Pittsburgh)H-Index: 17
#2Ying Tang (University of Pittsburgh)H-Index: 5
Last. Stephen Y. Chan (University of Pittsburgh)H-Index: 51
view all 12 authors...
Background Pulmonary hypertension (PH) is a deadly disease characterized by vascular stiffness and altered cellular metabolism. Current treatments focus on vasodilation and not other root causes of pathogenesis. Previously, it was demonstrated that glutamine metabolism, as catalyzed by GLS1 (glutaminase 1) activity, is mechanoactivated by matrix stiffening and the transcriptional coactivators YAP1 (yes-associated protein 1) and transcriptional coactivator with PDZ-binding motif (TAZ), resulting ...
Source
#1O ScholzH-Index: 1
#2Silke Otter (HHU: University of Düsseldorf)H-Index: 4
Last. Anna Hamacher (HHU: University of Düsseldorf)
view all 21 authors...
Dextromethorphan (DXM) acts as cough suppressant via its central action. Cell-protective effects of this drug have been reported in peripheral tissues, making DXM potentially useful for treatment of several common human diseases, such as type 2 diabetes mellitus (T2DM). Pancreatic islets are among the peripheral tissues that positively respond to DXM, and anti-diabetic effects of DXM were observed in two placebo-controlled, randomized clinical trials in humans with T2DM. Since these effects were...
Source
#1Richard MprahH-Index: 2
Last. Qiao Weili (Xuzhou Medical College)H-Index: 2
view all 9 authors...
Pulmonary arterial hypertension (PAH) is a decimating ailment described by chronic precapillary pulmonary hypertension, an elevated mean pulmonary arterial pressure with a normal pulmonary capillary wedge pressure, and a raised pulmonary vascular resistance resulting in increased right ventricular afterload culminating in heart failure and death. Current PAH treatments regulate the vasodilatory/vasoconstrictory balance of pulmonary vessels. However, these treatment options are unable to stop the...
1 CitationsSource
Objectives and Aims: Vascular smooth muscle cells (VSMCs) are key constituents of both normal arteries and atherosclerotic plaques. They have an ability to adapt to changes in the local environment by undergoing phenotypic modulation. An improved understanding of the mechanisms that regulate VSMC phenotypic changes may provide important insights that suggest new therapeutic targets in treatment of cardiovascular disease (CVD). The amino-acid glutamate has been associated with CVD risk and VSMCs ...
1 CitationsSource
#1Jason HongH-Index: 74
#2Douglas Arneson (UCLA: University of California, Los Angeles)H-Index: 9
Last. Xia Yang (UCLA: University of California, Los Angeles)H-Index: 39
view all 22 authors...
Rationale: The cellular and molecular landscape and translational value of commonly used models of pulmonary arterial hypertension (PAH) are poorly understood. Single-cell transcriptomics can enhan...
1 CitationsSource
#1Yi Na Dong (Children's Hospital of Philadelphia)H-Index: 6
#2Fu-Chun Hsu (Children's Hospital of Philadelphia)H-Index: 10
Last. David A. Lynch (Children's Hospital of Philadelphia)H-Index: 124
view all 16 authors...
N-methyl-D-aspartate (NMDA) receptors are widely expressed in the central nervous system. However, their presence and function at extraneuronal sites is less well characterized. In the present study, we examined the expression of NMDA receptor subunit mRNA and protein in human pulmonary artery (HPA) by quantitative polymerase chain reaction (PCR), immunohistochemistry and immunoblotting. We demonstrate that both GluN1 and GluN2 subunit mRNAs are expressed in HPA. In addition, GluN1 and GluN2 (A-...
Source
#1Fangcheng Luo (MOE: Chinese Ministry of Education)
#2Liangmiao Wu (MOE: Chinese Ministry of Education)
Last. Zaijun Zhang (MOE: Chinese Ministry of Education)
view all 12 authors...
Pulmonary arterial hypertension (PAH) is a rare, progressive pulmonary vascular disease with limited therapeutic options. Pulmonary circulation resistance, pulmonary vascular remodeling, and over-a...
Source